Stem cell treatment for multiple sclerosis (MS) is a promising new approach to addressing the disease’s progression and its associated symptoms. Our stem cell therapy for MS addresses its progressive and incapacitating symptoms while also supporting nerve cell repair by utilizing the Wharton’s jelly, mesenchymal stem cells’ powerful healing mechanisms.
Multiple Sclerosis is a serious condition that attacks the nervous system directly. MS gradually damages the brain, spinal cord, and optic nerves. In severe cases, the patient may become paralyzed, blind, and experience an unpredictable disease course.
Stem cell therapy for multiple sclerosis is a promising new approach to addressing the disease’s progression and its associated symptoms. Our stem cell treatment for MS addresses the progressive and incapacitating symptoms while also supporting nerve cell repair.
Our stem cell treatment for MS uses the healing properties of mesenchymal stem cells (MSCs). MSCs support and stimulate nerve tissue repair, support a reduction in inflammation, and may prevent further nerve cell death. MSCs are signaling molecules that can detect changes that cause pain or dysfunction. Once damage is detected, these healing, signaling cells – which act as central nervous system protectors – migrate to brain tissue damaged myelin zones and support repair.
Stemwell’s stem cell treatments for MS can addresses its debilitating symptoms, while at the same time supporting a long-term strategy of healing and repair. Implanting Wharton’s jelly-derived stem cells into the affected area effectively floods it with pure MSCs, also known as “repair cells.” They:
Stemwell’s proprietary delivery protocols target the blood-brain barrier (BBB) to ensure that the processed stem cells travel directly into the brain. This supports reestablishing blood flow, supports repairing damaged nerve cells (or neurons) and, most importantly, supports myelin sheathing restoration.
Stemwell uses umbilical cord tissue-derived mesenchymal stem cells, ethically sourced from full-term healthy human umbilical cords. We administer more than 300 million cells that are all thoroughly tested for viability before treatment. These cells are NOT a blood product; therefore, it is extremely safe and does not require HLA or phenotypic matching.
Video call with our patient advocates and our doctors where the patient’s condition and medical history will be discussed.
The patient undergoes an initial evaluation and blood work by Stemwell’s doctor.
Endovenous detox therapy applied to patient
Stem Cell IV Infusion Therapy + localized Autologous stem cell injections in trigger pain points under sedation
The fifth step is dedicated to addressing multiple sclerosis (MS) through specialized therapies, including shockwave therapy, ultrasound, magnetotherapy, and laser therapy.
In certain cases, we may also utilize photobiomodulation to address MS symptoms or explore its potential benefits for related neurological conditions and anti-aging treatments.
We all take simple daily tasks for granted, such as getting out of bed in the morning, walking, or even talking to our loved ones. All of these seemingly simple functions, however, are completely dependent on a functioning central nervous system.
As an example, when a healthy person decides to get out of bed, their brain makes the decision to stand up. Nerve cells, protected by myelin sheaths, communicate with one another via pathways that connect them throughout the nervous system. The brain sends signals along this nervous system network, through the spinal cord, and to the person’s extremities, causing him or her to stand up and get out of bed.
However, in a person with MS, the myelin sheaths are mistakenly attacked by the person’s own immune system, destroying this protective cover and, as a result, the underlying nerve fiber is inevitably damaged. It is then impossible for nerve cells to transmit signals and perform their functions, so the person gradually loses control of their own body. As the disease progresses, ongoing inflammation and nerve tissue damage result in temporary and permanent symptoms such as numbness, paralysis, and blindness.
Stemwell uses ethically sourced, human umbilical cord stem cells for MS treatment. They and are used to treat autoimmune diseases (allogeneic mesenchymal). These stem cells are expanded in our cutting-edge laboratory.
The mesenchymal stem cells we use are recovered from donated, healthy umbilical cords following normal, healthy births. Each mother’s medical history is checked, and she is tested for infectious diseases on multiple occasions. Prior to donation, each family provides written consent.
Before being approved for use in patients, all umbilical cord-derived stem cells are tested for infectious diseases in accordance with International Blood Bank Standards.
Only a small percentage of donated umbilical cords make it through our stringent screening process.
Our mission is to bring hope, healing, and a personalized plan to every patient we meet. We believe the caring hands and expertise of our doctors along with our proven protocols provide the best possible outcomes. We follow the highest ethical international standards offering transparency, honesty, and clinical accuracy.
Email
[email protected]
Address
Cra. 13 #118-08, Bogotá, Colombia
Telephone
+57 314 8079475
+57 601 3789412
Stem cell therapy offers no guarantees and is not promoted as a cure. This is similar to many other medical treatments. Reviewing the patient’s medical history is necessary to determine stem cell therapy eligibility. Any personal information provided is for internal and medical use with our medical providers only. The Stemwell Health headquarters is located in McLean, Virginia. Stemwell Health Virginia is not a stem cell treatment facility or surgical center. Treatments are not conducted anywhere in the US, since these advanced therapies are not yet FDA-approved. All cell therapies are conducted in Colombia where it is regulated by the ministry of health, INVIMA (Columbia’s FDA equivalent) and other local authorities. All treatments are performed within the country’s legal limits and regulatory framework where the specific medical provider practices.
